The Biden administration plans to spend more than $3 billion on projects to discover, develop and manufacture antiviral drugs for the prevention of illness and death from COVID-19. This investment is for
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.